Cyclerion Therapeutics Balance Sheet (2018-2025) | CYCN

Balance Sheet Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)
41.43M70.39M62.50M53.96M41.12M30.32M20.41M13.38M7.17M5.64M9.11M7.57M5.70M4.59M2.87M3.23M3.64M3.01M4.57M3.24M
Cash & Current Investments (Quarter)
41.43M70.39M62.50M53.96M41.12M30.32M20.41M13.38M7.17M5.64M9.11M7.57M5.70M4.59M2.87M3.23M3.64M3.01M4.57M3.24M
Receivables - Net (Quarter)
0.16M0.10M0.23M0.23M0.23M0.10M0.10M0.04M0.56M0.58M0.53M0.10M1.00M
Receivables - Other (Quarter)
Receivables (Quarter)
0.16M0.10M0.23M0.23M0.23M0.10M0.10M0.04M0.56M0.58M0.53M0.10M1.00M
Prepaid Assets (Quarter)
1.80M0.77M0.46M0.93M1.01M0.48M0.54M0.54M0.50M1.04M0.03M0.44M0.31M0.12M0.62M0.02M0.26M0.03M0.01M0.38M
Current Assets (Quarter)
44.45M72.99M63.68M55.46M42.84M31.68M21.66M14.82M8.34M7.11M9.86M8.02M6.01M4.71M3.55M4.22M4.50M4.02M5.07M4.63M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.07M0.15M0.11M0.07M0.02M
Long-Term Investments (Quarter)
5.35M5.35M5.35M5.35M5.35M5.35M5.35M5.35M5.35M5.35M
Other Non-Current Assets (Quarter)
2.68M2.59M2.41M2.32M2.22M2.13M2.04M1.95M1.86M
Non-Current Assets (Quarter)
55.52M2.74M4.06M3.87M3.69M3.53M3.40M3.26M3.12M2.98M5.35M5.35M5.35M5.35M5.35M5.35M5.35M5.35M5.35M5.35M
Assets (Quarter)
99.97M75.73M67.74M59.33M46.52M35.21M25.05M18.08M11.46M10.10M15.21M13.37M11.36M10.06M8.90M9.57M9.85M9.37M10.41M9.98M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.09M1.39M1.17M1.83M2.52M2.77M1.65M2.97M3.92M1.86M0.81M1.20M0.74M0.65M0.30M0.39M0.48M0.46M0.48M0.51M
Notes Payables (Quarter)
3.51M3.51M3.51M
Payables (Quarter)
4.60M4.89M4.68M1.83M2.52M2.77M1.65M2.97M3.92M1.86M0.81M1.20M0.74M0.65M0.30M0.39M0.48M0.46M0.48M0.51M
Accumulated Expenses (Quarter)
1.62M2.24M3.43M2.43M2.33M4.32M0.81M1.60M0.21M0.02M0.80M0.02M0.10M0.07M0.28M0.05M0.07M0.05M0.01M
Other Accumulated Expenses (Quarter)
Current Leases (Quarter)
1.40M
Total Current Liabilities (Quarter)
13.47M10.51M11.36M11.09M9.49M9.85M8.53M7.63M7.53M4.95M2.34M2.09M1.44M1.28M0.70M0.72M1.07M0.80M0.88M0.90M
Non-Current Liabilities
Operating Leases (Quarter)
38.07M
Other Non-Current Liabilities (Quarter)
Total Non-Current Liabilities (Quarter)
Total Liabilities (Quarter)
51.53M10.51M11.36M11.09M9.49M9.85M8.53M7.63M7.53M4.95M2.34M2.09M1.44M1.28M0.70M0.72M1.07M0.80M0.88M0.90M
Shareholder's Equity
Common Equity (Quarter)
48.43M65.22M56.39M48.25M37.03M25.36M16.52M10.45M3.92M5.15M12.87M11.29M9.92M8.78M8.20M8.85M8.78M8.57M9.54M9.09M
Shareholder's Equity (Quarter)
48.43M65.22M56.39M48.25M37.03M25.36M16.52M10.45M3.92M5.15M12.87M11.29M9.92M8.78M8.20M8.85M8.78M8.57M9.54M9.09M
Liabilities and Shareholders Equity (Quarter)
99.97M75.73M67.74M59.33M46.52M35.21M25.05M18.08M11.46M10.10M15.21M13.37M11.36M10.06M8.90M9.57M9.85M9.37M10.41M9.98M
Retained Earnings (Quarter)
-0.03M-193.01M-204.30M-215.08M-228.05M-241.44M-0.03M-0.02M-0.02M-0.02M-262.72M-264.42M-0.02M-267.30M-268.02M-267.49M-268.92M-269.25M-270.22M-271.02M
Treasury Shares (Quarter)
0.05M0.13M0.15M0.09M0.05M0.04M0.04M0.81M0.03M0.17M0.21M0.19M0.18M0.16M0.15M0.13M0.12M0.10M